Klivira
Request demo

Streamlining UnitedHealthcare Tezspire Prior Authorization for Severe Asthma

Efficiently managing UnitedHealthcare Tezspire prior authorization is critical for ensuring timely access to this essential biologic for severe asthma patients. Klivira streamlines the complex process, integrating directly with payer systems.

Revenue cycle directors and prior authorization coordinators face significant administrative burdens with high-volume specialty drug PAs. For a biologic like Tezspire, understanding UnitedHealthcare's specific requirements, submission channels, and policy nuances is paramount to minimizing delays and denials, thereby improving patient care pathways.

Understanding Tezspire Prior Authorization with UnitedHealthcare

Tezspire, a TSLP blocker approved as an add-on maintenance treatment for severe asthma, is a high-cost specialty medication that consistently requires prior authorization across UnitedHealthcare's commercial, Medicare Advantage, and Medicaid managed care plans. Given its nature as an injectable biologic, its coverage and PA requirements may fall under either the medical or pharmacy benefit, often managed through OptumRx, UnitedHealth Group's PBM.

UnitedHealthcare Submission Channels for Tezspire

  • **UHCprovider.com Portal:** For medical benefit prior authorizations, offering direct submission and status tracking.
  • **X12 278 Transactions:** Accepted through clearinghouses for eligible medical benefit procedures.
  • **OptumRx Provider Portal:** The primary channel for pharmacy benefit and specialty drug prior authorizations.
  • **CoverMyMeds / Surescripts:** Electronic prior authorization (ePA) platforms for prescriber-initiated pharmacy benefit workflows.

Medical Necessity Criteria and Policy Access for Tezspire

UnitedHealthcare publishes its medical necessity criteria and coverage rules for specialty drugs, including Tezspire, within its public Medical Policy Library. These policies outline specific clinical indications, step therapy requirements, and patient selection criteria that must be met for approval. Providers should consult the relevant policy number and effective date to ensure compliance with current guidelines.

Turnaround Times and Regulatory Compliance for Tezspire PAs

  • **State Regulations:** Commercial PA timeframes are governed by state insurance regulations applicable to the policyholder's state.
  • **NCQA Accreditation:** UHC's Utilization Management operations for commercial and Medicare Advantage plans adhere to NCQA standards.
  • **CMS-0057-F:** Applicable for Medicare Advantage and UnitedHealthcare Community Plan (Medicaid managed care) lines, mandating specific electronic PA API conformance and decision timeframes by 2027.

Common Denial Reasons and Appeal Pathways for Tezspire

  • **Medical Necessity:** Lack of documented clinical criteria or insufficient supporting evidence for severe asthma.
  • **Step Therapy:** Failure to document required preceding therapies as per policy.
  • **Site-of-Service Mismatch:** For infusions, if the requested site does not align with UnitedHealthcare's site-of-care policies.
  • **Off-Label Use:** Tezspire use outside of FDA-approved indications without compendium support.
  • **Benefit Exclusion:** Specific exclusions within the member's plan for specialty medications.

Automating Tezspire Prior Authorizations with Klivira

Klivira automates the submission and tracking of UnitedHealthcare Tezspire prior authorization, integrating with your EMR and connecting directly to UHC's provider portals and OptumRx's systems. Our platform streamlines the intake of clinical data, automates form completion, and monitors PA status, significantly reducing manual effort and accelerating approval cycles for this critical biologic.

Frequently asked questions

How does UnitedHealthcare determine coverage for Tezspire?

UnitedHealthcare determines Tezspire coverage based on its Medical Policy Library, which outlines specific clinical criteria, patient selection, and step therapy requirements for severe asthma. These policies may reference external standards, and providers should consult the current policy for detailed requirements.

Which OptumRx channel handles Tezspire prior authorizations?

As a specialty biologic, Tezspire prior authorizations are typically handled through OptumRx's provider PA system for pharmacy benefit submissions. Electronic submissions can also be facilitated via ePA partners like CoverMyMeds and Surescripts for prescriber-initiated workflows.

What are the typical turnaround times for Tezspire PA with UnitedHealthcare?

Turnaround times vary by line of business and state. Commercial plans adhere to state-mandated minimums, while Medicare Advantage and Medicaid plans are subject to CMS-0057-F, requiring 72-hour standard and 24-hour expedited decisions, with phased compliance through 2027.

What are common reasons for Tezspire PA denials from UnitedHealthcare?

Common denial reasons include insufficient clinical documentation to meet medical necessity criteria, failure to demonstrate compliance with step therapy protocols, or requesting use outside of approved indications without compendium support. Site-of-service mismatch may also be a factor for infusions.

Can I appeal a denied Tezspire prior authorization with UnitedHealthcare?

Yes, UnitedHealthcare provides a structured appeal pathway, detailed in its provider administrative guides. This process includes opportunities for peer-to-peer reviews for clinical denials and expedited appeal options for urgent care needs. Pathways differ by line of business.

Related coverage

Other tezspire prior authorization by payer

Other tezspire prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo